RT Journal Article
SR Electronic
T1 COVID-19 Vaccine Acceptance and Hesitancy in Low and Middle Income Countries, and Implications for Messaging
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.11.21253419
DO 10.1101/2021.03.11.21253419
A1 Arce, Julio S. Solís
A1 Warren, Shana S.
A1 Meriggi, Niccoló F.
A1 Scacco, Alexandra
A1 McMurry, Nina
A1 Voors, Maarten
A1 Syunyaev, Georgiy
A1 Malik, Amyn Abdul
A1 Aboutajdine, Samya
A1 Armand, Alex
A1 Asad, Saher
A1 Augsburg, Britta
A1 Bancalari, Antonella
A1 Nyqvist, Martina Björkman
A1 Borisova, Ekaterina
A1 Bosancianu, Constantin Manuel
A1 Cheema, Ali
A1 Collins, Elliott
A1 Farooqi, Ahsan Zia
A1 Fracchia, Mattia
A1 Guariso, Andrea
A1 Hasanain, Ali
A1 Kamwesigye, Anthony
A1 Kreps, Sarah
A1 Levine, Madison
A1 Littman, Rebecca
A1 Platas, Melina
A1 Ramakrishna, Vasudha
A1 Shapiro, Jacob N.
A1 Svensson, Jakob
A1 Vernot, Corey
A1 Vicente, Pedro C.
A1 Weissinger, Laurin B
A1 Zhang, Baobao
A1 Karlan, Dean
A1 Callen, Michael
A1 Teachout, Matthieu
A1 Humphreys, Macartan
A1 Omer, Saad B.
A1 Mobarak, Ahmed Mushfiq
YR 2021
UL http://medrxiv.org/content/early/2021/03/13/2021.03.11.21253419.abstract
AB Background As vaccination campaigns are deployed worldwide, addressing vaccine hesitancy is of critical importance to ensure sufficient immunization coverage. We analyzed COVID-19 vaccine acceptance across 15 samples covering ten low- and middle-income countries (LMICs) in Asia, Africa, and South America, and two higher income countries (Russia and the United States).Methods Standardized survey responses were collected from ‘45,928 individuals between June 2020 and January 2021. We estimate vaccine acceptance with robust standard errors clustered at the study level. We analyze stated reasons for vaccine acceptance and hesitancy, and the most trusted sources for advice on vaccination, and we disaggregate acceptance rates by gender, age, and education level.Findings We document willingness to take a COVID-19 vaccine across LMIC samples, ranging from 67% (Burkina Faso) to 97% (Nepal). Willingness was considerably higher in LMICs (80%) than in the United States (65%) and Russia (30%). Vaccine acceptance was primarily explained by an interest in personal protection against the disease (91%). Concern about side effects (40%) was the most common reason for reluctance. Health workers were considered the most trusted sources of information about COVID-19 vaccines.Interpretation Given high levels of stated willingness to accept a COVID-19 vaccine across LMIC samples, our study suggests that prioritizing efficient and equitable vaccine distribution to LMICs will yield high returns in promoting immunization on a global scale. Messaging and other community-level interventions in these contexts should be designed to help translate intentions into uptake, and emphasize safety and efficacy. Trusted health workers are ideally positioned to deliver these messages.Funding Beyond Conflict, Bill and Melinda Gates Foundation, Columbia University, Givewell.org, Ghent University, HSE University Basic Research Program, International Growth Centre, Jameel Poverty Action Lab Crime and Violence Initiative, London School of Economics and Political Science, Mulago Foundation, NOVAFRICA at the Nova School of Business and Economics, NYU Abu Dhabi, Oxford Policy Management, Social Science Research Council, Trinity College Dublin COVID19Response Funding, UK Aid, UKRI GCRF/Newton Fund, United Nations Office for Project Services, Weiss Family Fund, WZB Berlin Social Science Center, Yale Institute for Global Health, Yale Macmillan Center, and anonymous donors to IPA and Y-RISECompeting Interest StatementThe authors have declared no competing interest.Funding StatementBeyond Conflict, Bill and Melinda Gates Foundation, Columbia University, Givewell.org, Ghent University, HSE University Basic Research Program, International Growth Centre, Jameel Poverty Action Lab Crime and Violence Initiative, London School of Economics and Political Science, Mulago Foundation, NOVAFRICA at the Nova School of Business and Economics, NYU Abu Dhabi, Oxford Policy Management, Social Science Research Council, Trinity College Dublin COVID19 Response Funding, UK Aid, UKRI GCRF/Newton Fund, United Nations Office for Project Services, Weiss Family Fund, WZB Berlin Social Science Center, Yale Institute for Global Health, Yale Macmillan Center, and anonymous donors to IPA and Y-RISE.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This research was approved by multiple IRBs and they are listed in the appendix.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCode and output of the analysis can be consulted here https://wzb-ipi.github.io/covid_vaccines/replication.html. https://wzb-ipi.github.io/covid_vaccines/replication.html